Clearpoint Neuro Stock

Clearpoint Neuro Current Assets

The Current Assets of Clearpoint Neuro (CLPT) as of Aug 22, 2026 is 56.34 M USD. In the previous year, Current Assets was 33.36 M USD — a change of 68.86% (higher).

Current Assets

56.34 MUSD

YoY

68.86%

Last updated:

Current Assets of Clearpoint Neuro is 2026 56.34 M USD. Current Assets of Clearpoint Neuro was 2025 33.36 M USD. It decreases by 68.86% higher compared to the previous year.

The Clearpoint Neuro Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
6.65 M USD
Jan 1, 2019
10.38 M USD
Jan 1, 2020
25.46 M USD
Jan 1, 2021
61.90 M USD
Jan 1, 2022
51.19 M USD
Jan 1, 2023
35.44 M USD
Jan 1, 2024
33.36 M USD
Jan 1, 2025
56.34 M USD
The Clearpoint Neuro Current Assets history
YEARCurrent AssetsYoY
56.34 MUSD+68.86%
33.36 MUSD-5.86%
35.44 MUSD-30.76%
51.19 MUSD-17.30%
61.90 MUSD+143.10%
25.46 MUSD+145.19%
10.38 MUSD+56.13%
6.65 MUSD-47.82%
12.75 MUSD+109.34%
6.09 MUSD-28.65%
8.53 MUSD-27.11%
11.71 MUSD+97.17%
5.94 MUSD+92.76%
3.08 MUSD+100.81%
1.53 MUSD+5,013.56%
30,000.00USD-99.06%
3.20 MUSD-67.84%
9.95 MUSD
Access this data via the Eulerpool API

Clearpoint Neuro Stock analysis

What does Clearpoint Neuro do? Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and marketing of advanced medical products and systems. The company was founded in 1998 and is headquartered in Irvine, California. Clearpoint Neuro's primary goal is to provide better care and treatment for patients with neurological disorders. Clearpoint Neuro was originally founded in 1998 under the name MRI Intervention to meet the market demand for innovative navigation systems for minimally invasive brain procedures. The company's initial products included imaging devices used during surgery. Since then, the company has expanded its product portfolio and strengthened its market position by focusing on core tasks in the field of medical technology. In 2011, MRI Intervention rebranded as Clearpoint Neuro to accommodate its growing product portfolio. The company now primarily focuses on the development and marketing of platform technologies for the control of minimally invasive instruments during neurosurgical procedures. Its customers include hospitals and research institutions that specialize in neurological and neuroscience applications. Clearpoint Neuro has built an extremely successful business model that specializes in providing advanced medical technology to benefit patients. The company works closely with leading neurosurgeons and researchers to understand the needs of patients and develop the most advanced technologies aimed at improving patient treatment. Clearpoint Neuro is a B2B (Business to Business) company that sells its products and services to hospitals and research institutions to ensure that its products are used by medical professionals with appropriate education and experience. The company also has a strong presence in the academic world, where it focuses on collaborating with laboratories and universities to advance the latest developments in technology and research. The divisions of Clearpoint Neuro include medical product areas developed from its technology base, which are described in more detail in the following sections. ClearPoint System ClearPoint is an intraoperative MRI system that is available as a core component of neurosurgical intervention platforms. It uses advanced technology for real-time localization and navigation of instruments to perform minimally invasive brain surgeries. It utilizes imaging technologies to enable navigation and coordination during the surgical procedure. ClearPoint Neuro Therapies ClearPoint Neuro Therapies includes three main areas: "DBS," "MRI-Guided Focused Ultrasound," and "Laser Therapy." DBS (Deep Brain Stimulation) is a minimally invasive neural therapy that involves the insertion of thin electrodes into the brain using a specially existing surgical technique to treat degenerative diseases, particularly Parkinson's disease. Another highly innovative therapy option is MRI-Guided Focused Ultrasound therapy, which targets and precisely destroys cancer cells using focused ultrasound waves. ClearPoint Neuro is one of the leading providers of this advanced therapy. Laser therapy involves the destruction of selected neural cells using heat. ClearPoint Neuro Navigation ClearPoint Neuro's navigation technologies are leading in neurosurgery and research. Navigation allows for precise placement of needles in the brain to obtain biopsies under ultrasound guidance or to administer medication targetedly without damaging the brain. The system is used by neurosurgeons and researchers worldwide. In conclusion, Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and manufacturing of advanced systems and products for neurosurgery and research. The company has built a strong business model by working closely with leading neurosurgeons and researchers and developing the most advanced technologies aimed at improving the quality of patient care. The ClearPoint System, ClearPoint Neuro Therapies, and ClearPoint Neuro Navigation divisions play a significant role in its success. Clearpoint Neuro is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Clearpoint Neuro stock

Current Assets of Clearpoint Neuro is 56.34 M USD in 2026.

Current Assets of Clearpoint Neuro changed from 33.36 M USD to 56.34 M USD, representing a 68.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Clearpoint Neuro since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Clearpoint Neuro historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Clearpoint Neuro

All Key Metrics — Clearpoint Neuro